How many institutions held JAGX - Jaguar Health, Inc. - Common Stock, par value $0.0001 per share in Q2 2025?

7 institutional investors reported JAGX - Jaguar Health, Inc. - Common Stock, par value $0.0001 per share for Q2 2025. Use the holders table for investor-level position and value details.

Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (JAGX)

Q: What does CUSIP 47010C888 represent in this 13F holders report?

CUSIP 47010C888 is the security identifier for JAGX - Jaguar Health, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 47010C888

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 6,991,905
Total 13F shares: 13,684
Share change: +8,627
Total reported value: $34,714
Price per share: $2.52
Number of holders: 7
Value change: +$21,735
Number of buys: 3
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 47010C888?
CUSIP 47010C888 identifies JAGX - Jaguar Health, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025
Previous quarter: Q1 2025

Recent filing periods for CUSIP 47010C888:

Q4 2025 Q3 2025 Q2 2025 Q1 2025

Top shareholders of JAGX - Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
INTRACOASTAL CAPITAL, LLC	13D/G	Mitchell P. Kopin	5%	65,002	$779,374	$0	20 May 2025	13D/G
Uptown Capital, LLC	13D/G	John Fife and Fredrick Waid	9.9%	1,290,000	$322,500	$0	29 Jan 2025	13D/G
UBS Group AG	13F	Company	0.06%	4,315	$20,539	—	31 Mar 2025	13F
ROYAL BANK OF CANADA	13F	Company	0.01%	702	$3,000	—	31 Mar 2025	13F
Leonteq Securities AG	13F	Company	0%	188	$901	—	31 Mar 2025	13F
Gregory J. Divis	3/4/5	Director	— class O/S missing	12,133	$364	—	18 May 2022	3/4/5
SBI Securities Co., Ltd.	13F	Company	0%	20	$95	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	0%	10	$48	—	31 Mar 2025	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	4	$19	—	31 Mar 2025	13F
BlackRock, Inc.	13F	Company	0%	4	$19	—	31 Mar 2025	13F
DANSKE BANK A/S	13F	Company	0%	2	$10	—	31 Mar 2025	13F

Institutional Holders of Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (JAGX) as of Q2 2025

As of 30 Jun 2025, Jaguar Health, Inc. - Common Stock, par value $0.0001 per share (JAGX) was held by 7 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,684 shares. The largest 8 holders included UBS Group AG, Tower Research Capital LLC (TRC), Royal Bank of Canada, SBI Securities Co., Ltd., Leonteq Securities AG, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, and BlackRock, Inc.. This page lists 8 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders

Q2 2025 holders

Holder diff

Investor	Q1 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.